Krainer Adrian R. 4
4 · Stoke Therapeutics, Inc. · Filed Sep 12, 2019
Insider Transaction Report
Form 4
Krainer Adrian R.
Director
Transactions
- Award
Director Stock Option (Right to Buy)
2019-09-10+14,777→ 14,777 totalExercise: $28.80Exp: 2029-09-09→ Common Stock (14,777 underlying)
Footnotes (1)
- [F1]This option vests 100% and becomes exercisable on June 21, 2020, subject to reporting person's continued service through such vesting date.